Clinical Trial Update: Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating deep brain stimulation for treatment-refractory negative symptoms in schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia; Negative Type | Phase 1 | Status: WITHDRAWN